Article Text

Download PDFPDF
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Both authors contributed to the design and writing of the commentary.

  • Funding MB-V was supported by Cholangiocarcinoma Foundation (CCF) Research Fellowship, and by the Postdoctoral Fellowship Grant from Ramon Areces Foundation. PB was supported by Instituto de Salud Carlos III (PI22/00147) co-financed by Fondos Feder, Gobierno de Navarra Proyecto ARNMUNE Ref: 0011–1411-2023, and a 2022 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer-reviewed.

Linked Articles